Future research will need to evaluate the clinical utility of serum HO-1 measurement in patients with each of the various histopathological diagnoses (e.g., IPF, NSIP, and organizing pneumonia). The gene discussed is HMOX1; the disease is idiopathic pulmonary fibrosis.